Can Technology Make Pathology More Human? Part 2

• by Helen Bristow

• September 4, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation

• by Julia Konings, Fleur Mingneau, Serhii Chornyi, Cathrin E. Hansen, Rianne T. M. van der Burgt, Tessa G. van Elk, Laura Bolkaerts, Bo Batens, Gábor Tóth, Ingela Lanekoff, Frédéric M. Vaz, Alessio Cardilli, Marie Sels, Susanne M. A. van der Pol, Helga E. de Vries, Martin Giera, Oliver Werz, Sofie Kessels, Sanne G. S. Verberk, Jeroen F. J. Bogie, Merel Rijnsburger, Jerome J. A. Hendriks, Gijs Kooij

• September 4, 2026

Blood Biomarker May Help Women Avoid Chemotherapy

Ultrasensitive measures of ovarian reserve could refine treatment decisions for younger women with hormone receptor–positive breast cancer

• August 28, 2026

• 2 min